NASDAQ:ARAY Accuray (ARAY) Stock Price, News & Analysis $2.80 -0.28 (-9.09%) Closing price 11/13/2026 04:00 PM EasternExtended Trading$3.17 +0.37 (+13.25%) As of 11/13/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Accuray Stock (NASDAQ:ARAY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Accuray alerts:Sign Up Key Stats Today's Range$2.75▼$3.0850-Day Range$2.80▼$12.0752-Week Range$2.75▼$45.20Volume140,574 shsAverage Volume75,054 shsMarket Capitalization$8.37 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingReduce Company Overview Accuray Incorporated develops, manufactures, and sells radiation therapy systems and related software for treating cancer and other conditions. Its technologies are used by hospitals and cancer treatment centers to plan and deliver radiation treatments. The company’s products include the CyberKnife platform, a robotic system designed to deliver stereotactic radiosurgery and radiation therapy, and the Radixact platform, which uses helical tomotherapy to deliver image-guided radiation treatments. Accuray also provides treatment-planning software, service, and support for its systems. Founded in 1990, Accuray serves healthcare providers in the United States and internationally. The company is headquartered in Madison, Wisconsin.AI Generated. May Contain Errors. Read More Accuray Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks19th Percentile Overall ScoreARAY MarketRank™: 0.96952180767 of 5 starsAccuray scored higher than 19% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.0 / 5Analyst RatingReduce Consensus RatingAccuray has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.Amount of Analyst CoverageAccuray has only been the subject of 1 research reports in the past 90 days.Read more about Accuray's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Accuray is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Accuray is -0.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAccuray has a P/B Ratio of 0.16. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.86% of the float of Accuray has been sold short.Short Interest Ratio / Days to CoverAccuray has a short interest ratio ("days to cover") of 2.87, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Accuray has recently increased by 11.15%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAccuray does not currently pay a dividend.Dividend GrowthAccuray does not have a long track record of dividend growth. News and Social Media3.4 / 5News Sentiment0.36 News SentimentAccuray has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Accuray this week, compared to 2 articles on an average week.Search Interest1 people have searched for ARAY on MarketBeat in the last 30 days. MarketBeat Follows4 people have added Accuray to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Accuray insiders have not sold or bought any company stock.Percentage Held by Insiders3.50% of the stock of Accuray is held by insiders.Percentage Held by Institutions64.08% of the stock of Accuray is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Accuray's insider trading history. Receive ARAY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accuray and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ARAY Stock News HeadlinesAccuray (NASDAQ:ARAY) Stock Rating Raised to Hold at Wall Street ZenNovember 14 at 1:25 AM | americanbankingnews.comAccuray Completes Major Financing Transaction with TCWNovember 13 at 5:51 PM | tipranks.comWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indicator for a single $7 payment. Others previously paid $500. The indicator flashes a Crash Alert as a cue to exit or go short, and a Bull Run Alert as a cue to buy or go long. No strings attached, and Wood says there is an unusual reason behind the steep discount.November 15 at 1:00 AM | Base Camp Trading (Ad)Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value GrowthNovember 13 at 5:10 PM | prnewswire.comAccuray Incorporated Announces Goodwill Impairment for the First Quarter Ended September 30, 2026November 5, 2026 | marketscreener.comMAccuray (ARAY) Q1 2027 Earnings Call TranscriptNovember 5, 2026 | finance.yahoo.comTranscript : Accuray Incorporated, Q1 2027 Earnings Call, Nov 04, 2026November 5, 2026 | marketscreener.comMAccuray Incorporated: Accuray Reports Fiscal 2027 First Quarter Financial ResultsNovember 5, 2026 | finanznachrichten.deSee More Headlines ARAY Stock Analysis - Frequently Asked Questions How have ARAY shares performed this year? Accuray's stock was trading at $32.9840 at the start of the year. Since then, ARAY stock has decreased by 91.5% and is now trading at $2.80. How were Accuray's earnings last quarter? Accuray Incorporated (NASDAQ:ARAY) posted its quarterly earnings data on Wednesday, August, 19th. The medical equipment provider reported ($0.80) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.20) by $0.40. The medical equipment provider had revenue of $100.92 million for the quarter, compared to analysts' expectations of $105.30 million. Accuray had a negative trailing twelve-month return on equity of 35.36% and a negative net margin of 4.41%. Read the conference call transcript. When did Accuray's stock split? Shares of Accuray reverse split on Monday, November 9th 2026.A 1-40 reverse split was announced. The number of shares owned by shareholders was adjusted after the market closes on Sunday, November 8th 2026. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. Does Accuray have any subsidiaries? Accuray subsidiaries include these companies: Morphormics Inc., TomoTherapy Incorporated, Accuray Accelerator Technology (Chengdu) Company Limited, Accuray Asia Ltd., Accuray Belgium BVBA, Accuray Brasil Comércio, Accuray Cayman Islands, and others. Who are Accuray's major shareholders? Accuray's top institutional shareholders include Weber Capital Management LLC ADV (4.05%), Kovack Advisors Inc. (37.66%), State Street Corp (15.64%) and Williams & Novak Wealth Management LLC (0.25%). Insiders that own company stock include Suzanne C Winter, Joseph E Whitters, Michael Hoge, Ali Pervaiz, Patrick Spine, Gina Corradetti and Neve Stephen R La. View institutional ownership trends. How do I buy shares of Accuray? Shares of ARAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Accuray own? Based on aggregate information from My MarketBeat watchlists, some other companies that Accuray investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Micron Technology (MU), Palantir Technologies (PLTR), PayPal (PYPL) and Qualcomm (QCOM). Company Calendar Last Earnings8/19/2026Today11/15/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (12m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 ARAY's financial health is in the Red zone, according to TradeSmith. ARAY has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:ARAY CIK1138723 Webwww.accuray.com Phone(608) 824-2800Fax408-716-4601Employees809Year Founded1990Profitability EPS (Trailing Twelve Months)($6.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$49.19 million Net Margins-4.41% Pretax Margin-3.90% Return on Equity-35.36% Return on Assets-3.88% Debt Debt-to-Equity Ratio1.79 Current Ratio1.56 Quick Ratio0.74 Sales & Book Value Annual Sales$401.95 million Price / Sales0.02 Cash FlowN/A Price / Cash FlowN/A Book Value$17.77 per share Price / Book0.16Miscellaneous Outstanding Shares2,990,000Free Float2,884,000Market Cap$8.37 million OptionableOptionable Beta1.38 Social Links 7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.Get This Free Report This page (NASDAQ:ARAY) was last updated on 11/13/2026 by MarketBeat.com Staff. From Our PartnersWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | SponsoredTrump’s EO to send this $5 stock ripping higher…?President Trump's December executive order declared space a national security and economic priority, fueling a...Traders Agency | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredUnbelievable…Congress is About to Do What?Jim Rickards, former advisor to the CIA, the Pentagon and the White House, says a key turning point in Washing...Paradigm Press | SponsoredUranium Mine Flood That Sparked a 2006 Price Surge ReturnsIn 2006, a flooded mine at Cigar Lake sent uranium prices from the $50 range to $136 in eight months. This pa...Digest Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accuray Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Accuray With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.